Skip to content

Colgate-Palmolive CL Oral, Personal and Home Care — Acquisitions

Other segment segments

Pet Nutrition
$207M

Similar metrics at other companies

Stewart Information Services logo
STCCorporate — Acquisitions
$0
La-Z-Boy logo
LZBCorporate and Other — Acquisitions
$0
Helen Of Troy logo
HELEHome & Outdoor — Acquisitions
$0
American Tower logo
AMTAcquisitions
$19.2M-87.0%
MSCI logo
MSCIAll Other - Private Assets — Acquisitions
$11.6M
Service Corporation International logo
SCIAcquisitions
$24.09M+62.0%

Other financials

Income statement

See full
Revenue$5.3B+8.4%
Gross profit$3.2B+8.0%
Operating income$964.0M-10.4%
Net income$646.0M-6.4%
EPS (diluted)$0.80-5.9%

Balance sheet

See full
Cash & equivalents$1.3B+20.1%
Total debt$8.0B-3.6%
Total equity$145.0M-60.1%
Total assets$16.6B-0.2%

Cash flow

See full
Operating cash flow$747.0M+24.5%
CapEx$138.0M+11.3%
Free cash flow$609.0M+27.9%

Valuation

See full
Market cap$73.67B+3.1%
Enterprise value$80.31B+1.7%
P/E34.7×+10.1×
P/S3.5×0.0×

Profitability

See full
Gross margin60.1%-0.6pp
Operating margin15.4%-6.2pp
Net margin10.2%-4.3pp
FCF margin18.1%+0.7pp

Returns & leverage

See full
Return on equity836.2%-141pp
Debt / equity55×+32.2×
Current ratio+0.2×

Where this comes from

Reported directly by Colgate-Palmolive in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The official record: Colgate-Palmolive’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Colgate-Palmolive's oral, personal and home care — acquisitions.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Colgate-Palmolive's oral, personal and home care — acquisitions?
Colgate-Palmolive (CL) reported oral, personal and home care — acquisitions of $0 in Q4 2025.
What does oral, personal and home care — acquisitions mean?
This metric captures the total capital deployed for the purchase of external businesses, brands, or product lines to expand market share or capabilities. It is a key indicator of the company's inorganic growth strategy and its ability to integrate new assets into its existing portfolio. Investors use this to evaluate the cost and frequency of the company's external expansion efforts.